JESSILYN POZO: Open Payments
NPI 1366158040 · HOMESTEAD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$467 in 24 payments from 8 companies in 2025. Trend: 2023 $297 · 2024 $467 · 2025 $467
Food & beverage: $467
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $156 |
| AstraZeneca Pharmaceuticals LP | 5 | $111 |
| PFIZER INC. | 3 | $68 |
| MDD US Operations, LLC | 2 | $46 |
| UCB, Inc. | 1 | $30 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $18 |
| ACADIA Pharmaceuticals Inc | 1 | $17 |
Products named: VYALEV, WAINUA, ELIQUIS, Fintepla, Apokyn, INGREZZA, Ozempic, NUPLAZID.
Industry payments across FL — which companies pay providers there.
